Berner Industrier delivered another strong year in 2025, with margin gains and cost discipline lifti...
We expect relatively healthy Q4 results despite the weak macroeconomic situation in Finland.
Redeye comments on Gapwaves' Q4 2025 report, which exceeded expectations on both net sales and adjus...
Redeye comments on Friday’s press release, in which Enviro announced that it has received a request ...
* 2026 recovery after two challenging years * '26e-'27e EBIT down 35-24%; ~60% EBIT CAGR '25-'28e * ...
* A surprising sequential margin decline in Q4... * .
Tagmaster finished 2025 with record level sales and earnings in the fourth quarter.
Redeye takes a slightly more positive view following the Q4 report, showing even stronger momentum i...
DT’s outlook is turning much brighter now as security CT volumes are recovering after the slump seen...
2025 was a record year for Endomines, with profitability improving clearly, although H2 fell slightl...
* Strong FM&WT EBIT margin (19% vs. ABGSCe 15%) * We trim our margin estimates for Decommissioning a...
Redeye comments on the directed share issue to Carl Bennet AB of SEK45.
As we highlighted in our initiation of coverage report, Berner Industrier’s previous financial targe...
Redeye provides its initial take on Lagercrantz’s Q3 2025/2026 report, which showed strong EBITA gro...
Redeye provides its initial take on CTEK’s Q4 numbers, where sales were slightly lower than expected...
SyntheticMR reported its full Q4, showing headline figures in line with preliminary figures.
Berner Industrier continues to impress with a solid 62% y/y improvement in adj.
Duni reported a weak Q4 with sales of SEK 1,965m, 7% below SEB, and operating income of SEK 162m, 11...
Redeye provides its initial take on MedCap’s Q4 2025 report, which came in broadly in line with our ...
Redeye updates on Evolution post Q4-results which were close to our forecasts while the company’s ma...
